Benzinga | Oct 22, 2021 06:33AM EDT

SVB Leerink Maintains Outperform on Merck & Co, Raises Price Target to $105

SVB Leerink analyst Daina Graybosch maintains Merck & Co (NYSE:MRK) with a Outperform and raises the price target from $104 to $105.